Harrow, Inc. Files 2024 10-K Annual Report
Ticker: HROW · Form: 10-K · Filed: Mar 27, 2025 · CIK: 1360214
| Field | Detail |
|---|---|
| Company | Harrow, INC. (HROW) |
| Form Type | 10-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Harrow Inc. dropped its 2024 10-K. All eyes on 2025.
AI Summary
Harrow, Inc. filed its 2024 10-K on March 27, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Harrow Health, Inc., operates in the pharmaceutical preparations sector. Key financial details and operational highlights for 2024 are presented in this comprehensive annual report.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of Harrow, Inc.'s financial performance, strategic initiatives, and risk factors for the fiscal year 2024, enabling informed investment decisions.
Risk Assessment
Risk Level: medium — The company operates in the pharmaceutical sector, which is subject to significant regulatory, competitive, and market risks.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-27 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- HARROW, INC. (company) — Filer
- 20241231 (date) — Fiscal Year End
- 20250327 (date) — Filing Date
- Harrow Health, Inc. (company) — Former Company Name
- Imprimis Pharmaceuticals, Inc. (company) — Former Company Name
- TRANSDEL PHARMACEUTICALS INC (company) — Former Company Name
- HROW:Sec8.625SeniorNotesDue2026Member (dollar_amount) — Debt Instrument
- HROW:Sec11.875SeniorNotesDue2027Member (dollar_amount) — Debt Instrument
FAQ
What was Harrow, Inc.'s fiscal year end for this filing?
Harrow, Inc.'s fiscal year end was December 31, 2024.
When was this 10-K filing submitted to the SEC?
This 10-K filing was submitted on March 27, 2025.
What is Harrow, Inc.'s Standard Industrial Classification code?
Harrow, Inc.'s Standard Industrial Classification code is 2834, Pharmaceutical Preparations.
Has Harrow, Inc. operated under previous names?
Yes, Harrow, Inc. has operated under the names Harrow Health, Inc., Imprimis Pharmaceuticals, Inc., and TRANSDEL PHARMACEUTICALS INC.
What are some of the debt instruments mentioned for Harrow, Inc.?
The filing mentions HROW:Sec8.625SeniorNotesDue2026Member and HROW:Sec11.875SeniorNotesDue2027Member.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 27, 2025 regarding HARROW, INC. (HROW).